Cite
HARVARD Citation
Blagden, S. et al. (2020). Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial. Lancet oncology. 21 (7), pp. 969-977. [Online].